The Incidence, Characteristics, Impact and Risk Factors of Post-COVID Chronic Pain in Thailand: A Single-center Cross-sectional Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2024 Jan 12

PMID 38215071

Authors

Suratsawadee Wangnamthip

Nantthasorn Zinboonyahgoon

Pranee Rushatamukayanunt

Patcha Papaisarn

Burapa Pajina

Thanawut Jitsinthunun

Panuwat Promsin

Rujipas Sirijatuphat

Cesar Fernandez-de-Las-Penas

Lars Arendt-Nielsen

Daniel Ciampi de Andrade

Affiliations

Soon will be listed here.

Abstract

The COVID-19 pandemic has affected millions of individuals worldwide. Pain has emerged as a significant post-COVID-19 symptom. This study investigated the incidence, characteristics, and risk factors of post-COVID chronic pain (PCCP) in Thailand. A cross-sectional study was conducted in participants who had been infected, including those hospitalized and monitored at home by SARS-CoV-2 from August to September 2021. Data were collected for screening from medical records, and phone interviews were done between 3 to 6 months post-infection. Participants were classified into 1) no-pain, 2) PCCP, 3) chronic pain that has been aggravated by COVID-19, or 4) chronic pain that has not been aggravated by COVID-19. Pain interference and quality of life were evaluated with the Brief Pain Inventory and EuroQol Five Dimensions Five Levels Questionnaire. From 1,019 participants, 90% of the participants had mild infection, assessed by WHO progression scale. The overall incidence of PCCP was 3.2% (95% CI 2.3-4.5), with 2.8% (95% CI 2.0-4.1) in mild infection, 5.2% (95% CI 1.2-14.1) in moderate infection and 8.5% (95% CI 3.4-19.9) in severe infection. Most participants (83.3%) reported pain in the back and lower extremities and were classified as musculoskeletal pain and headache (8.3%). Risk factors associated with PCCP, included female sex (relative risk [RR] 2.2, 95% CI 1.0-4.9) and greater COVID-19 severity (RR 3.5, 95% CI 1.1-11.7). Participants with COVID-19-related exacerbated chronic pain displayed higher pain interferences and lower utility scores than other groups. In conclusion, this study highlights the incidence, features, and risk factors of post-COVID chronic pain (PCCP) in Thailand. It emphasizes the need to monitor and address PCCP, especially in severe cases, among females, and individuals with a history of chronic pain to improve their quality of life in the context of the ongoing COVID-19 pandemic.

References

Fernandez-de-Las-Penas C, Martin-Guerrero J, Florencio L, Navarro-Pardo E, Rodriguez-Jimenez J, Torres-Macho J . Clustering analysis reveals different profiles associating long-term post-COVID symptoms, COVID-19 symptoms at hospital admission and previous medical co-morbidities in previously hospitalized COVID-19 survivors. Infection. 2022; 51(1):61-69. PMC: 9028890. DOI: 10.1007/s15010-022-01822-x. View

Lai Y, Liu S, Manachevakul S, Lee T, Kuo C, Bello D . Biomarkers in long COVID-19: A systematic review. Front Med (Lausanne). 2023; 10:1085988. PMC: 9895110. DOI: 10.3389/fmed.2023.1085988. View

Ekholm O, Diasso P, Davidsen M, Kurita G, Sjogren P . Increasing prevalence of chronic non-cancer pain in Denmark from 2000 to 2017: A population-based survey. Eur J Pain. 2021; 26(3):624-633. DOI: 10.1002/ejp.1886. View

Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mule G . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. 2021; 28(4):611.e9-611.e16. PMC: 8575536. DOI: 10.1016/j.cmi.2021.11.002. View

Treede R, Rief W, Barke A, Aziz Q, Bennett M, Benoliel R . Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2018; 160(1):19-27. DOI: 10.1097/j.pain.0000000000001384. View

Kemp H, Corner E, Colvin L . Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020; 125(4):436-440. PMC: 7261464. DOI: 10.1016/j.bja.2020.05.021. View

Mazza M, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I . Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020; 89:594-600. PMC: 7390748. DOI: 10.1016/j.bbi.2020.07.037. View

. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020; 20(8):e192-e197. PMC: 7292605. DOI: 10.1016/S1473-3099(20)30483-7. View

Kubota G, Soares F, da Fonseca A, Rosa T, da Silva V, Gouveia G . Pain paths among post-COVID-19 condition subjects: A prospective cross-sectional study with in-person evaluation. Eur J Pain. 2023; 27(5):636-650. DOI: 10.1002/ejp.2094. View

10.

Anaya J, Rojas M, Salinas M, Rodriguez Y, Roa G, Lozano M . Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021; 20(11):102947. PMC: 8428988. DOI: 10.1016/j.autrev.2021.102947. View

11.

Fernandez-de-Las-Penas C, Herrero-Montes M, Cancela-Cilleruelo I, Rodriguez-Jimenez J, Paras-Bravo P, Varol U . Understanding Sensitization, Cognitive and Neuropathic Associated Mechanisms behind Post-COVID Pain: A Network Analysis. Diagnostics (Basel). 2022; 12(7). PMC: 9316513. DOI: 10.3390/diagnostics12071538. View

12.

Ortiz F, Santos M, Landenberger T, Emmanuelli B, Agostini B, Ardenghi T . Comparison of Face-To-Face Interview and Telephone Methods of Administration on the Ecohis Scores. Braz Dent J. 2016; 27(5):613-618. DOI: 10.1590/0103-6440201601134. View

13.

Clauw D, Hauser W, Cohen S, Fitzcharles M . Considering the potential for an increase in chronic pain after the COVID-19 pandemic. Pain. 2020; 161(8):1694-1697. PMC: 7302093. DOI: 10.1097/j.pain.0000000000001950. View

14.

Zajacova A, Grol-Prokopczyk H, Fillingim R . Beyond Black vs White: racial/ethnic disparities in chronic pain including Hispanic, Asian, Native American, and multiracial US adults. Pain. 2022; 163(9):1688-1699. PMC: 9294074. DOI: 10.1097/j.pain.0000000000002574. View

15.

Maglietta G, Diodati F, Puntoni M, Lazzarelli S, Marcomini B, Patrizi L . Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J Clin Med. 2022; 11(6). PMC: 8948827. DOI: 10.3390/jcm11061541. View

16.

Soares F, Kubota G, Fernandes A, Hojo B, Couras C, Costa B . Prevalence and characteristics of new-onset pain in COVID-19 survivours, a controlled study. Eur J Pain. 2021; 25(6):1342-1354. PMC: 8013219. DOI: 10.1002/ejp.1755. View

17.

Mohamed Zaki L, Hairi N . A Systematic Review of the Prevalence and Measurement of Chronic Pain in Asian Adults. Pain Manag Nurs. 2014; 16(3):440-52. DOI: 10.1016/j.pmn.2014.08.012. View

18.

Fayaz A, Croft P, Langford R, Donaldson L, Jones G . Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open. 2016; 6(6):e010364. PMC: 4932255. DOI: 10.1136/bmjopen-2015-010364. View

19.

Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med. 2022; 54(1):1473-1487. PMC: 9132392. DOI: 10.1080/07853890.2022.2076901. View

20.

Fiala K, Martens J, Abd-Elsayed A . Post-COVID Pain Syndromes. Curr Pain Headache Rep. 2022; 26(5):379-383. PMC: 8907389. DOI: 10.1007/s11916-022-01038-6. View